Xiong, A., Wang, J., & Zhou, C. (2021). Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Xiong, Anwen, Jiali Wang, y Caicun Zhou. Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Xiong, Anwen, et al. Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.